Induction or aggravation of other immune mediated disorders by disease-modifying-therapy for treatment of multiple sclerosis

  • Seyed Mohammad Baghbanian Bualicina Hospital, Mazandaran University of Medical sciences, Sari, Iran
  • Mohammad Ali Sahraian Multiple Sclerosis Research Centre, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
Keywords: Interferon-Beta, Glatiramer Acetate, Autoimmune Disease, Multiple Sclerosis

Abstract

-
Published
2018-07-05
How to Cite
1.
Baghbanian SM, Sahraian MA. Induction or aggravation of other immune mediated disorders by disease-modifying-therapy for treatment of multiple sclerosis. IJNL. 17(3).
Section
Review Article(s)